Answers are grounded in this paper and cite their sources.
Highlights from the Literature| June 04 2024 Editors' Selections from Relevant Scientific Publications Author & Article Information Online ISSN: 1940-6215 Print ISSN: 1940-6207 ©2024 American Association for Cancer Research2024American Association for Cancer Research Cancer Prev Res (Phila) (2024) 17 (6): 241. https://doi.org/10.1158/1940-6207.CAPR-17-6-HFL Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn Email Tools Icon Tools Get Permissions Cite Icon Cite Search Site Article Versions Icon Versions Version of Record June 4 2024 Citation Editors' Selections from Relevant Scientific Publications. Cancer Prev Res (Phila) 1 June 2024; 17 (6): 241. https://doi.org/10.1158/1940-6207.CAPR-17-6-HFL Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest Search Advanced Search Immune detection of cancer cells (via Cancer Discovery) Upregulated transcription factor SOX17 aids early colorectal adenomas and cancers in immune escape. Goto et al. orthotopically transplanted mouse colonic organoids harboring Apc-null, KrasG12D, and Trp53-null mutations (naïve AKP organoids) into immunocompetent mice, passaged them 4-6 times and then retrieved primary tumor-derived AKP organoids. Compared to naïve AKP organoids, tumor-derived organoids showed significant upregulation of SOX17, which was also expressed in premalignant adenomas and early-stage colorectal tumors from human patients. Deletion of Sox17 through CRISPR-Cas9 editing in tumor-derived AKP organoids inhibited tumor growth in immunocompetent, but not immunodeficient, mice. The few Sox17-null tumors that did grow contained more interferon-γ (IFNγ)-producing effector-like T cells than wildtype counterparts. The authors further showed that SOX17 suppressed tumor cells' ability to sense and respond to IFNγ and that SOX17 repressed the expression of LGR5 and major histocompatibility complex class I for immune evasion. The... You do not currently have access to this content.
No takes yet. Share an insight, caveat, or question.
A 2024 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: